Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive.
Sapsford
R J
RJ
Robinson
M B
MB
Hall
A S
AS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D011307:Drug Prescriptions; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin